EYPT
Price
$9.85
Change
-$0.18 (-1.79%)
Updated
Jul 29 closing price
Capitalization
677.8M
Earnings call today
VNDA
Price
$4.67
Change
-$0.02 (-0.43%)
Updated
Jul 29, 04:59 PM (EDT)
Capitalization
275.81M
One day until earnings call
Interact to see
Advertisement

EYPT vs VNDA

Header iconEYPT vs VNDA Comparison
Open Charts EYPT vs VNDABanner chart's image
EyePoint Pharmaceuticals
Price$9.85
Change-$0.18 (-1.79%)
Volume$371.26K
Capitalization677.8M
Vanda Pharmaceuticals
Price$4.67
Change-$0.02 (-0.43%)
Volume$6.14K
Capitalization275.81M
EYPT vs VNDA Comparison Chart in %
Loading...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EYPT vs. VNDA commentary
Jul 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EYPT is a Buy and VNDA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 30, 2025
Stock price -- (EYPT: $9.85 vs. VNDA: $4.68)
Brand notoriety: EYPT and VNDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EYPT: 48% vs. VNDA: 84%
Market capitalization -- EYPT: $677.8M vs. VNDA: $275.81M
EYPT [@Biotechnology] is valued at $677.8M. VNDA’s [@Biotechnology] market capitalization is $275.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $315.74B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EYPT’s FA Score shows that 1 FA rating(s) are green whileVNDA’s FA Score has 1 green FA rating(s).

  • EYPT’s FA Score: 1 green, 4 red.
  • VNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, EYPT is a better buy in the long-term than VNDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EYPT’s TA Score shows that 5 TA indicator(s) are bullish while VNDA’s TA Score has 3 bullish TA indicator(s).

  • EYPT’s TA Score: 5 bullish, 4 bearish.
  • VNDA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, EYPT is a better buy in the short-term than VNDA.

Price Growth

EYPT (@Biotechnology) experienced а -5.74% price change this week, while VNDA (@Biotechnology) price change was -0.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.71%. For the same industry, the average monthly price growth was +15.03%, and the average quarterly price growth was +41.55%.

Reported Earning Dates

EYPT is expected to report earnings on Oct 29, 2025.

VNDA is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+2.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EYPT($678M) has a higher market cap than VNDA($276M). EYPT YTD gains are higher at: 32.215 vs. VNDA (-2.296). VNDA has higher annual earnings (EBITDA): -64.56M vs. EYPT (-144.55M). VNDA has more cash in the bank: 341M vs. EYPT (318M). VNDA has less debt than EYPT: VNDA (11.7M) vs EYPT (24.1M). VNDA has higher revenues than EYPT: VNDA (201M) vs EYPT (56M).
EYPTVNDAEYPT / VNDA
Capitalization678M276M246%
EBITDA-144.55M-64.56M224%
Gain YTD32.215-2.296-1,403%
P/E RatioN/A126.00-
Revenue56M201M28%
Total Cash318M341M93%
Total Debt24.1M11.7M206%
FUNDAMENTALS RATINGS
EYPT vs VNDA: Fundamental Ratings
EYPT
VNDA
OUTLOOK RATING
1..100
6859
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
83
Overvalued
PROFIT vs RISK RATING
1..100
88100
SMR RATING
1..100
9792
PRICE GROWTH RATING
1..100
4255
P/E GROWTH RATING
1..100
172
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EYPT's Valuation (58) in the Pharmaceuticals Major industry is in the same range as VNDA (83) in the Biotechnology industry. This means that EYPT’s stock grew similarly to VNDA’s over the last 12 months.

EYPT's Profit vs Risk Rating (88) in the Pharmaceuticals Major industry is in the same range as VNDA (100) in the Biotechnology industry. This means that EYPT’s stock grew similarly to VNDA’s over the last 12 months.

VNDA's SMR Rating (92) in the Biotechnology industry is in the same range as EYPT (97) in the Pharmaceuticals Major industry. This means that VNDA’s stock grew similarly to EYPT’s over the last 12 months.

EYPT's Price Growth Rating (42) in the Pharmaceuticals Major industry is in the same range as VNDA (55) in the Biotechnology industry. This means that EYPT’s stock grew similarly to VNDA’s over the last 12 months.

VNDA's P/E Growth Rating (2) in the Biotechnology industry is in the same range as EYPT (17) in the Pharmaceuticals Major industry. This means that VNDA’s stock grew similarly to EYPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EYPTVNDA
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 12 days ago
86%
Bullish Trend 7 days ago
71%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 2 days ago
69%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
74%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIUSX34.07N/A
N/A
Macquarie Opportunity A
FITIX21.96N/A
N/A
Fidelity Advisor Mid Cap II M
POLIX49.14N/A
N/A
Polen Growth Institutional
WELNX10.39N/A
N/A
William Blair Emerging Mkts Ldrs N
VCKSX10.95N/A
N/A
Virtus KAR Small-Mid Cap Growth C

VNDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VNDA has been loosely correlated with CLDX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if VNDA jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNDA
1D Price
Change %
VNDA100%
-0.43%
CLDX - VNDA
41%
Loosely correlated
-0.27%
OCUL - VNDA
41%
Loosely correlated
-2.57%
PGEN - VNDA
40%
Loosely correlated
-0.63%
EYPT - VNDA
40%
Loosely correlated
-1.79%
IVF - VNDA
40%
Loosely correlated
-13.60%
More